Endurant Capital Management as of June 30, 2019
Portfolio Holdings for Endurant Capital Management
Endurant Capital Management holds 50 positions in its portfolio as reported in the June 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Takeda Pharmaceutical (TAK) | 6.5 | $17M | 933k | 17.70 | |
| Laboratory Corp. of America Holdings (LH) | 5.7 | $14M | 83k | 172.90 | |
| Zimmer Holdings (ZBH) | 5.1 | $13M | 110k | 117.74 | |
| Wright Medical Group Nv | 4.4 | $11M | 372k | 29.82 | |
| R1 Rcm | 4.1 | $11M | 831k | 12.58 | |
| Cigna Corp (CI) | 3.8 | $9.7M | 62k | 157.56 | |
| Pra Health Sciences | 3.8 | $9.6M | 97k | 99.15 | |
| IntriCon Corporation | 3.6 | $9.1M | 390k | 23.36 | |
| Oxford Immunotec Global | 3.4 | $8.7M | 629k | 13.76 | |
| Fluidigm Corporation convertible cor | 3.3 | $8.4M | 8.8M | 0.96 | |
| Irhythm Technologies (IRTC) | 3.2 | $8.2M | 103k | 79.08 | |
| Sientra | 3.1 | $7.9M | 1.3M | 6.16 | |
| Humana (HUM) | 2.9 | $7.4M | 28k | 265.32 | |
| Encompass Health Corp (EHC) | 2.9 | $7.3M | 115k | 63.36 | |
| Avedro | 2.8 | $7.0M | 358k | 19.64 | |
| AtriCure (ATRC) | 2.6 | $6.5M | 219k | 29.84 | |
| Vocera Communications | 2.5 | $6.5M | 203k | 31.92 | |
| Abbvie (ABBV) | 2.5 | $6.5M | 89k | 72.72 | |
| AmerisourceBergen (COR) | 2.5 | $6.3M | 74k | 85.26 | |
| Intersect Ent | 2.4 | $6.2M | 271k | 22.76 | |
| Hca Holdings (HCA) | 2.3 | $5.9M | 44k | 135.18 | |
| Sanofi-Aventis SA (SNY) | 2.1 | $5.2M | 121k | 43.27 | |
| AstraZeneca (AZN) | 2.0 | $5.2M | 125k | 41.28 | |
| Evolent Health Inc bond | 2.0 | $5.0M | 5.6M | 0.89 | |
| Dentsply Sirona (XRAY) | 1.9 | $4.8M | 83k | 58.36 | |
| Iovance Biotherapeutics (IOVA) | 1.7 | $4.2M | 173k | 24.52 | |
| Nevro (NVRO) | 1.6 | $4.1M | 63k | 64.83 | |
| Bristol Myers Squibb (BMY) | 1.5 | $3.9M | 86k | 45.35 | |
| Liquidia Technologies (LQDA) | 1.5 | $3.8M | 469k | 8.00 | |
| Aclaris Therapeutics (ACRS) | 1.4 | $3.6M | 1.6M | 2.19 | |
| Gw Pharmaceuticals Plc ads | 1.2 | $3.1M | 18k | 172.38 | |
| Integra LifeSciences Holdings (IART) | 0.9 | $2.4M | 43k | 55.85 | |
| Surgery Partners (SGRY) | 0.9 | $2.3M | 288k | 8.14 | |
| Neon Therapeutics | 0.9 | $2.2M | 466k | 4.74 | |
| Osmotica Pharmaceuticals (RVLPQ) | 0.8 | $2.0M | 514k | 3.80 | |
| DaVita (DVA) | 0.7 | $1.8M | 33k | 56.25 | |
| Gritstone Oncology Ord (GRTS) | 0.6 | $1.6M | 144k | 11.14 | |
| Senseonics Hldgs Inc note 5.250% 2/0 | 0.6 | $1.5M | 1.5M | 1.03 | |
| Marinus Pharmaceuticals | 0.6 | $1.5M | 362k | 4.15 | |
| Si-bone (SIBN) | 0.5 | $1.3M | 65k | 20.33 | |
| Tandem Diabetes Care (TNDM) | 0.5 | $1.3M | 20k | 64.51 | |
| Bio-Rad Laboratories (BIO) | 0.5 | $1.2M | 3.7k | 312.72 | |
| Genocea Biosciences (GNCAQ) | 0.5 | $1.1M | 290k | 3.92 | |
| Mednax (MD) | 0.4 | $994k | 39k | 25.23 | |
| Actinium Pharmaceuticals | 0.2 | $620k | 2.5M | 0.25 | |
| Sarepta Therapeutics (SRPT) | 0.2 | $570k | 3.8k | 151.88 | |
| Align Technology (ALGN) | 0.2 | $537k | 2.0k | 273.70 | |
| Glycomimetics (GLYC) | 0.2 | $504k | 42k | 11.92 | |
| Translate Bio | 0.2 | $490k | 39k | 12.64 | |
| Adverum Biotechnologies | 0.1 | $379k | 32k | 11.89 |
